1. Home
  2. TK vs DRTS Comparison

TK vs DRTS Comparison

Compare TK & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

N/A

Current Price

$14.56

Market Cap

1.2B

ML Signal

N/A

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

N/A

Current Price

$14.58

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TK
DRTS
Founded
1973
2015
Country
Bermuda
Israel
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
TK
DRTS
Price
$14.56
$14.58
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $17.80
AVG Volume (30 Days)
★ 489.4K
443.8K
Earning Date
10-28-2026
11-19-2026
Dividend Yield
★ 7.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,235.59
P/E Ratio
$13.43
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.80
$3.43
52 Week High
$14.93
$15.79

Technical Indicators

Market Signals
Indicator
TK
DRTS
Relative Strength Index (RSI) 57.10 51.78
Support Level $13.06 $13.73
Resistance Level $14.30 $15.01
Average True Range (ATR) 0.44 0.59
MACD -0.08 -0.07
Stochastic Oscillator 50.00 40.18

Price Performance

Historical Comparison
TK
DRTS

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: